The health authorities of Sweden have announced this Wednesday the suspension of the use of the modern vaccine against Coronavirus under 30 years due to possible side effects.
The Danish Ministry of Health has cited a possible risk of pathologies that include cardiac disorders such as myocarditis and pericarditis.
“We are supervising the situation and we are acting quickly to ensure that vaccination against COVID-19 is as safe as possible, while trying to give adequate protection,” Anders Tegnell, head of epidemiology in the country.
Instead of using the doses of modern for the younger population, the Government has recommended the Pfizer vaccine for that age group, according to information from the ‘Aftonbladet’ newspaper.
“People who have recently vaccinated, with one or two doses, do not have to worry because the risk is very low,” said Tegnell, who has affirmed that “it is good to know the symptoms to be alert.”
The Danish government also announced this Wednesday the suspension of the administration of the Vaccine of Modern to those under 18, as reported by the newspaper ‘Berlingske’.
The health authority and medications of Denmark has indicated in a statement that children between 12 and 17 years old will be vaccinated with Pfizer.
“The modern and effective vaccine is a safe and efficient vaccine, we know that both with the modern vaccine and Pfizer / Biontech can cause in rare cases an inflammation of the cardiac muscle after vaccination”, collects the text.
“Fortunately, it is a disease that almost always disappears on its own. And if needed medical assistance, professionals are accustomed,” said the director of the National Health Board, Bolette Soborg.
Finland has also decided to suspend the use of modern in vaccination of males born from 1991 due to possible side effects detected, the Finnish health authorities have indicated this Thursday.
“A Nordic study that includes Finland, Sweden, Norway and Denmark has found that men under the age of 30 who have received the modern spikevax vaccine have a slightly greater risk than the remainder of developing myocarditis,” said Mika Salminen, responsible for
Institute of Health of Finland.
Norway, in fact, already recommended the use of the Pfizer (and non-modern) vaccine in minors and has reiterated its positioning.
European, American regulatory agencies and the World Health Organization have indicated that the benefits of this vaccination are superior to their risks.
